Birchview Capital »

BioCryst Pharmaceuticals shares owned by Birchview Capital

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Birchview Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $142k 20k 7.08
2023-06-30 $141k 20k 7.04
2023-03-31 $167k 20k 8.35
2022-12-31 $230k 20k 11.50
2022-09-30 $252k 20k 12.60
2022-06-30 $212k 20k 10.60
2022-03-31 $325k 20k 16.25
2021-12-31 $277k 20k 13.85
2021-09-30 $287k 20k 14.35
2021-06-30 $316k 20k 15.80
2021-03-31 $203k 20k 10.15
2020-12-31 $149k 20k 7.45
2020-09-30 $69k 20k 3.45
2020-06-30 $95k 20k 4.75
2020-03-31 $40k 20k 2.00
2019-12-31 $69k 20k 3.45
2019-09-30 $57k 20k 2.85
2019-06-30 $76k 20k 3.80